Selects former Schering legislative affairs director Dennis Jackman as the company's first director of government affairs. Previously, Jackman had served as legislative assistant to Sen. Specter (R-Penn.) and worked as a government and industry for Peat Marwick Main & Co. . . . Shering-Plough: Appoints Richard Kinney staff VP legislative affairs, effective July 1. Kinney, 49, who was Schering's director of state and community affairs, succeeds Diane Darneille. . . .
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
The FDA recommended removal of a voluntary hold on shipments of the gene therapy to younger patients after finding that the death of an 8-year-old boy in Brazil was unrelated to Elevidys. Discussions on safety of DMD treatment for non-ambulatory patients is ongoing.
While the 15% rate is a substantial blow for pharmaceutical firms, the US-EU deal provides a framework for trade agreements with other countries that could see the industry avoiding higher tariffs elsewhere.